Please enter a name for your new saved list

Create
Cancel

Nobivac Feline 1-HCP+FeLV Vaccine

Nobivac Feline 1-HCP+FeLV Vaccine

Supplied By: Merck (065265)


SKU
009456


Unit of
Measure
25 x 1 Dose


Pack
Type
Box


Case
Qty
1

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Dec- 2021 Nov- 2021 Oct- 2021 Sep- 2021 Aug- 2021 Jul- 2021 Jun- 2021 May- 2021 Apr- 2021 Mar- 2021 Feb- 2021 Jan- 2021 Dec- 2020
{{purchaseHistoryItem}}


SKU
009456


Size
25 x 1 Dose

Case
Qty
1

Purchase History

Dec- 2021 {{productPurchaseHistory['009456'][0]}} May- 2021 {{productPurchaseHistory['009456'][0+7]}}
Nov- 2021 {{productPurchaseHistory['009456'][1]}} Apr- 2021 {{productPurchaseHistory['009456'][1+7]}}
Oct- 2021 {{productPurchaseHistory['009456'][2]}} Mar- 2021 {{productPurchaseHistory['009456'][2+7]}}
Sep- 2021 {{productPurchaseHistory['009456'][3]}} Feb- 2021 {{productPurchaseHistory['009456'][3+7]}}
Aug- 2021 {{productPurchaseHistory['009456'][4]}} Jan- 2021 {{productPurchaseHistory['009456'][4+7]}}
Jul- 2021 {{productPurchaseHistory['009456'][5]}} Dec- 2020 {{productPurchaseHistory['009456'][5+7]}}
Jun- 2021 {{productPurchaseHistory['009456'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Features & Benefits

  • A quality core vaccine that protects against feline rhinotracheitis, feline panleukopenia virus (FPV), and feline calicivirus (FCV), in addition to providing extensive 2-year coverage for FeLV
  • Nobivac® Feline 1-HCP has been shown to block the replication of canine parvovirus (CPV) in cats
  • Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia
  • The only feline leukemia vaccine labeled to prevent persistent viremia for 2 years after vaccination
  • 96% of vaccinated cats were protected against persistent viremia after FeLV challenge
  • In a 2-year study involving 23 FeLV-negative cats:
  • After 12 weeks, 83% of vaccinates were free of persistent and transient viremia
  • All 11 control cats (100%) developed persistent viremia
  • Results showed that cats developed immunity solely through the initial vaccination series
  • Optimal choice for both indoor and outdoor cats

Compare and Save

{{CompareAndSaveSource.ProductName}}

{{CompareAndSaveSource.Sku}}
{{CompareAndSaveSource.Manufacturer}}
${{CompareAndSaveSource.SourcePrice.toFixed(2)}} ({{CompareAndSaveSource.UnitOfMeasure}})

{{CompareAndSaveProduct[0].ProductName}}

{{CompareAndSaveProduct[0].Sku}}
{{CompareAndSaveProduct[0].Manufacturer}}
${{CompareAndSaveProduct[0].UnitPrice.toFixed(2)}} ({{CompareAndSaveProduct[0].UnitOfMeasure}})
Potential Savings: ${{CompareAndSaveProduct[0].PotentialSavings.toFixed(2)}}
(Per Unit)

{{CompareAndSaveProduct[1].ProductName}}

{{CompareAndSaveProduct[1].Sku}}
{{CompareAndSaveProduct[1].Manufacturer}}
${{CompareAndSaveProduct[1].UnitPrice.toFixed(2)}} ({{CompareAndSaveProduct[1].UnitOfMeasure}})
Potential Savings: ${{CompareAndSaveProduct[1].PotentialSavings.toFixed(2)}}
(Per Unit)



Related Products

 

SIMPLIFY YOUR MAILBOX AND GO GREEN

Have you signed up for eStatements yet? They're a great way to receive less paper mail and keep your statements organized in your email inbox!

Learn More
covetrus_glyph_rgb w-TM-01

Careers

Are you looking for a place to let your talents shine? At Covetrus, we help our practitioner customers better serve their patients and take pride in providing the best customer experience possible. Search our open positions to see our available opportunities.

Learn More

Newsletter

Stay current with what’s going on with Covetrus, subscribe to receive our newsletter and email communications. Subscribers will receive the latest information in practice management, sales and marketing, animal health, and more.

Sign Up